JUN 10, 202655 MINS READ
Industrial grade diisopropylamine possesses a branched secondary amine structure wherein the nitrogen atom is bonded to two isopropyl groups, conferring significant steric hindrance around the reactive center. This structural feature is pivotal in determining its reactivity profile and selectivity in chemical transformations.
Key Physicochemical Parameters:
The basicity of diisopropylamine (pKa of conjugate acid ~11.0) positions it as a stronger base than primary amines but weaker than tertiary amines such as triethylamine, making it suitable for deprotonation reactions where controlled basicity is required. Its steric bulk reduces nucleophilicity compared to less hindered amines, enabling selective base-catalyzed reactions without competing nucleophilic addition 25.
Spectroscopic Characterization:
Industrial batches are routinely analyzed by ¹H NMR (characteristic doublet at δ 1.0–1.1 ppm for methyl groups and septet at δ 2.9–3.1 ppm for methine protons), ¹³C NMR (signals at ~23 ppm for CH₃ and ~48 ppm for CH groups), and GC-MS (M⁺ = 101) to confirm identity and purity 56.
The predominant industrial route involves the reductive amination of acetone with ammonia over supported metal catalysts (typically Ni, Co, or Pd on alumina or silica supports) under hydrogen pressure. This process proceeds via imine intermediate formation followed by hydrogenation:
2 (CH₃)₂CO + NH₃ + 2 H₂ → (CH₃)₂CH-NH-CH(CH₃)₂ + 2 H₂O
Optimized Reaction Conditions:
This method achieves 85–92% selectivity to diisopropylamine with 95–98% acetone conversion per pass 211. Primary amine (isopropylamine) and tertiary amine (triisopropylamine) by-products are separated by fractional distillation, with the primary amine recycled to the reactor to enhance secondary amine yield.
Laboratory-scale and specialty production may employ alkylation routes using isopropyl halides (typically isopropyl chloride or bromide) with ammonia or isopropylamine in the presence of base:
(CH₃)₂CHCl + (CH₃)₂CHNH₂ + Base → (CH₃)₂CH-NH-CH(CH₃)₂ + Base·HCl
Process Considerations:
This route is less favored industrially due to higher raw material costs (isopropyl halides vs. acetone), corrosive HX by-products requiring neutralization and disposal, and lower atom economy. However, it remains useful for small-scale production or when specific isotopic labeling is required 12.
Industrial grade diisopropylamine is purified by multi-stage fractional distillation under atmospheric or reduced pressure, achieving ≥99.0% purity with <0.5% isopropylamine, <0.3% triisopropylamine, and <0.1% water. Quality control protocols include:
Diisopropylamine and its N-ethyl derivative (N-ethyldiisopropylamine, DIPEA or Hünig's base) are extensively employed in pharmaceutical synthesis as non-nucleophilic bases that deprotonate acidic protons without competing nucleophilic attack on electrophilic centers. This property is critical in peptide bond formation, where carboxylic acid activation (via carbodiimides, phosphonium reagents, or acid chlorides) must proceed without base-mediated side reactions 567.
Representative Applications:
Case Study: Dasatinib Polymorph Synthesis
In the industrial crystallization of dasatinib (a tyrosine kinase inhibitor), N-ethyldiisopropylamine is used to deprotonate N-(2-hydroxyethyl)piperazine during coupling with a chloropyrimidine intermediate in DMSO at 76–85°C. The resulting solution is then treated with isopropanol (IPA) to induce crystallization of specific polymorphic forms (IPA-DMSO solvates) characterized by PXRD peaks at 6.0, 20.8, and 24.3° 2θ. This process achieves >95% conversion and >98% purity of the desired polymorph, critical for bioavailability and regulatory approval 67.
Diisopropylamine serves as a direct precursor or intermediate in the synthesis of various APIs:
Diisopropylamine is a key building block in the production of several herbicide families, particularly those targeting acetolactate synthase (ALS) or acetyl-CoA carboxylase (ACCase) enzymes in plants.
Specific Examples:
The basicity and coordinating ability of diisopropylamine enable its use as a ligand or catalyst in transition metal-catalyzed reactions:
Diisopropylamine and its salts (e.g., diisopropylamine nitrite) function as volatile corrosion inhibitors (VCIs) in steam-condensate systems and boiler water treatment. The amine neutralizes acidic species (CO₂, organic acids) and forms protective films on metal surfaces, reducing corrosion rates by 60–80% in carbon steel systems at dosages of 10–50 ppm 1112.
Mechanism:
Diisopropylamine is employed as a tertiary amine catalyst in polyurethane (PU) foam production, accelerating the reaction between isocyanates and polyols. Its steric hindrance provides selectivity for urethane (NCO + OH) over urea (NCO + H₂O) formation, critical for controlling foam density and cell structure.
Typical Formulation:
In epoxy resin systems, diisopropylamine functions as a curing agent or accelerator for amine-cured formulations, particularly in low-temperature cure applications (5–25°C). The secondary amine reacts with epoxide groups via nucleophilic ring-opening:
R-NH-R' + CH₂(O)CH-R'' → R-N(R')-CH₂-CH(OH)-R''
Curing Characteristics:
Industrial grade diisopropylamine is classified under multiple hazard categories:
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| BASF SE | Pharmaceutical synthesis requiring high-purity non-nucleophilic bases for peptide coupling, protecting group chemistry, and API intermediate production where impurity control is critical for regulatory compliance. | N-Ethyl-diisopropylamine Production Process | Catalytic reductive amination of acetaldehyde with diisopropylamine using Pd/Al2O3 or Pt/Al2O3 catalysts achieves high-yield, high-purity N-ethyl-diisopropylamine production with minimal by-product formation, enabling use of crude diisopropylamine feedstock containing water and isopropanol impurities. |
| TEVA PHARMACEUTICAL INDUSTRIES LTD. | Industrial-scale production of tyrosine kinase inhibitor APIs requiring precise polymorphic control for consistent therapeutic efficacy and regulatory approval in oncology drug manufacturing. | Dasatinib Polymorph Manufacturing | N-ethyldiisopropylamine enables selective crystallization of dasatinib IPA-DMSO solvate polymorphs with >95% conversion and >98% purity through controlled deprotonation at 76-85°C in DMSO, producing specific PXRD patterns at 6.0, 20.8, and 24.3° 2θ critical for bioavailability. |
| ZHEJIANG UNIVERSITY | Cost-effective production of pharmaceutical intermediates and specialty chemicals where environmental compliance and operational safety are prioritized over traditional halide-based alkylation methods. | N,N-Diisopropylethylamine Synthesis Technology | MIX-type catalyst enables direct alkylation of diisopropylamine with chloroethane at 130-230°C and 0.8-2.5 MPa, achieving simplified process with reduced waste generation compared to traditional routes using bromoethane or diethyl sulfate. |
| F. HOFFMANN-LA ROCHE AG | Medicinal chemistry and drug discovery applications requiring selective sulfonamide bond formation with controlled basicity to prevent nucleophilic competition in multi-step synthesis of bioactive heterocyclic compounds. | Isothiazolyl Sulfonamide Drug Synthesis | Diisopropylethylamine (3 equivalents) facilitates sulfonamide formation between sulfonyl chlorides and isothiazol amines at 23°C in dichloromethane, achieving 66% isolated yield with effective HCl neutralization and minimal side reactions in pharmaceutical intermediate synthesis. |
| UCB PHARMA GMBH | Pharmaceutical manufacturing of urological therapeutics requiring high-purity API bases with improved safety profiles and therapeutic efficacy for treatment of overactive bladder and related conditions. | 3,3-Diphenylpropylamine Drug Manufacturing | Selective reaction between diisopropylamine and carboxylic acid chlorides produces high-purity 3,3-diphenylpropylamine bases with low impurity content, enhancing safety and efficacy in bladder dysfunction treatment compared to existing drugs like Oxybutynin. |